Bionano Genomics (BNGO) Cash from Operations Growth (3y) (2020 - 2026)
Bionano Genomics (BNGO) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn | 16.81% |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | 53.64% |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 70.05% |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 25.17% |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn | -9.84% |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | -33.35% |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 13.75% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -8.92% |
| 10 | Bionano Genomics | 12.08 Mn | -1.61 Mn | 3.25 Mn | 43.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.97% |
| Dec 31, 2025 | 50.72% |
| Sep 30, 2025 | 41.44% |
| Jun 30, 2025 | 50.26% |
| Mar 31, 2025 | 56.02% |
| Dec 31, 2024 | 36.68% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | -19.09% |
| Mar 31, 2024 | -26.48% |
| Dec 31, 2023 | -35.00% |
| Sep 30, 2023 | -33.87% |
| Jun 30, 2023 | -71.95% |
| Mar 31, 2023 | -59.21% |
| Dec 31, 2022 | -54.54% |
| Sep 30, 2022 | -59.38% |
| Jun 30, 2022 | -64.92% |
| Mar 31, 2022 | -70.53% |
| Dec 31, 2021 | -84.34% |
| Sep 30, 2021 | -48.52% |
| Jun 30, 2021 | -61.17% |